14-3-3<i>η</i> Protein as a Potential Biomarker in Juvenile Idiopathic Arthritis
The 14-3-3<b><i>η</i></b> (eta) protein was evaluated as a biomarker in a cohort of patients with juvenile idiopathic arthritis (JIA), as well as disease- and healthy-controls, to determine its potential clinical utility. In this case-control study, levels of 14-3-3<b>&...
Main Authors: | Austin Dalrymple, Paul Tuttle, Lance Feller, Olga Zhukov, Robert Lagier, Joanna Popov, Stanley Naides, Terry Moore |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Pediatric Reports |
Subjects: | |
Online Access: | https://www.mdpi.com/2036-7503/13/1/8 |
Similar Items
-
Prevalence and significance of serum 14–3-3η in juvenile idiopathic arthritis
by: Iris Reyhan, et al.
Published: (2021-02-01) -
Juvenile idiopathic arthritis associated with a mutation in GATA3
by: Anna E. Patrick, et al.
Published: (2019-06-01) -
Juvenile Idiopathic Arthritis
by: Aleksandra Strońska, et al.
Published: (2021-08-01) -
Foxp3 Molecular Dynamics in Treg in Juvenile Idiopathic Arthritis
by: Alastair Copland, et al.
Published: (2018-10-01) -
A Proteinase 3 Contribution to Juvenile Idiopathic Arthritis-Associated Cartilage Damage
by: Eric K. Patterson, et al.
Published: (2021-06-01)